Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study.
Saved in:
| Title: | Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study. |
|---|---|
| Authors: | Zugasti, Ines1,2,3 (AUTHOR), Lopez-Guerra, Monica1,4,5 (AUTHOR), Castaño-Díez, Sandra1,2,4 (AUTHOR), Esteban, Daniel1,4,6 (AUTHOR), Avendaño, Alejandro2,7 (AUTHOR), Pomares, Helena2,8 (AUTHOR), Perez, Ana2,9 (AUTHOR), García-Ávila, Sara2,10 (AUTHOR), Conejo, Irene Padilla2,11 (AUTHOR), de la Fuente Montes, Cristina2,6 (AUTHOR), Martínez-Roca, Alexandra1,4 (AUTHOR), Merchán, Beatriz1,4 (AUTHOR), Jiménez-Vicente, Carlos1,4 (AUTHOR), Guijarro, Francesca1,4 (AUTHOR), Álamo, Jose Ramón1,4 (AUTHOR), Cortes-Bullich, Albert1,4 (AUTHOR), Torrecillas, Victor12 (AUTHOR), Mont, Lucia12 (AUTHOR), Carcelero, Esther1 (AUTHOR), Riu, Gisela1 (AUTHOR) |
| Source: | Experimental Hematology & Oncology. 4/26/2025, Vol. 14 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
